Detalhe da pesquisa
1.
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
Blood
; 143(16): 1616-1627, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215395
2.
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
N Engl J Med
; 379(26): 2517-2528, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501481
3.
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
J Clin Oncol
; 41(13): 2394-2402, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623230
4.
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.
J Clin Oncol
; 40(12): 1323-1334, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35044810
5.
Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538.
Lung Cancer
; 156: 68-71, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33894496
6.
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202.
Leukemia
; 35(10): 2854-2861, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34274940
7.
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.
J Thromb Haemost
; 18(2): 411-421, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31630479
8.
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.
J Clin Oncol
; 36(4): 326-332, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29136387
9.
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.
JAMA Oncol
; 3(8): 1043-1050, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28208174
10.
Images in vascular medicine: cement pulmonary embolism.
Vasc Med
; 15(4): 339-40, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20484312
11.
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).
J Clin Oncol
; 33(1): 13-21, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25092775
12.
Palliative irradiation of the spleen.
Am J Clin Oncol
; 26(2): 178-83, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12714892